NgM, FlemingT, RobinsonM, ThomsonB, GraetzN, MargonoC, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014; 384(9945):766–781.
2.
AkashibaT, KawaharaS, KosakaN, ItoD, SaitoO, MajimaT, et al. Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest, 2002; 121(2):415–421.
3.
NowbarS, BurkartKM, GonzalesR, FedorowiczA, GozanskyWS, GaudioJC, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med, 2004; 116(1):1–7.
4.
LaabanJ-P, ChailleuxE. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in france, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest, 2005; 127(3):710–715.
5.
MokhlesiB. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care, 55(10):1347–1362, 2010.
6.
GarnerDJ, BerlowitzDJ, DouglasJ, HarknessN, HowardM, McArdleN, et al. Home mechanical ventilation in Australia and New Zealand. Eur Respir J, 2013; 41(1):39–45.
7.
JanssensJP, DerivazS, BreitensteinE, De MuraltB, FittingJW, ChevroletJC, et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake Area. Chest, 2003; 123(1):67–79.
8.
MokhlesiB, KrygerMH, GrunsteinRR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc, 2008; 5(2):218–225.
9.
Perez de LlanoLA, GolpeR, Ortiz PiquerM, Veres RacamondeA, Vazquez CarunchoM, Caballero MuinelosO, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest, 2005; 128(2):587–594.
10.
KesslerR, ChaouatA, SchinkewitchP, FallerM, CaselS, KriegerJ, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest, 2001; 120(2):369–376.
11.
BergerKI, AyappaI, Chatr-AmontriB, MarfatiaA, SorkinIB, RapoportDM, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest, 2001; 120(4):1231–1238.
12.
BorelJC, BurelB, TamisierR, Dias-DomingosS, BaguetJP, LevyP, et al. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One, 2013; 8(1):e52006.
13.
Castro-AñónO, Pérez de LlanoLA, De la Fuente SánchezS, GolpeR, Méndez MaroteL, Castro-CastroJ, et al. Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One, 2015; 10(2):e0117808.
14.
PriouP, HamelJ-F, PersonC, MeslierN, RacineuxJ-L, UrbanT, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest, 2010; 138(1):84–90.
15.
BergG, DelaiveK, ManfredaJ, WalldR, KrygerMH. The use of health-care resources in obesity-hypoventilation syndrome. Chest, 2001; 120(2):377–383.
16.
HidaW. Quality of life in obesity hypoventilation syndrome. Sleep Breath, 2003; 7(1):1–2.
17.
OlsonAL, ZwillichC. The obesity hypoventilation syndrome. Am J Med, 2005; 118:948–956.
18.
SugermanHJ, FairmanRP, SoodRK, EngleK, WolfeL, KellumJM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr, 1992; 55(2 Suppl):597S–601S.
19.
MessikaJ, RicardJD. Evaluation of risk factors for high flow nasal oxygen failure: a means to avoid disillusion. J Crit Care, 2016; 32:222–223.
20.
DuarteAG, JustinoE, BiglerT, GradyJ. Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure. Crit Care Med, 2007; 35(3):732–737.
21.
ShivaramU, CashME, BealA. Nasal continuous positive airway pressure in decompensated hypercapnic respiratory failure as a complication of sleep apnea. Chest, 1993; 104(3):770–774.
22.
GonzálezÁO, RomeroGP-B, OrmaecheaIF, FloresRC, de FrutosNC, MangadoNG. [Evolution of patients with chronic obstructive pulmonary disease, obesity hypoventilation syndrome, or congestive heart failure undergoing noninvasive ventilation in a respiratory monitoring unit.]. Arch Bronconeumol, 2006; 42(9):423–429.
Ramírez-MolinaVR, Gómez-de-TerrerosFJ, Barca-DuránJ, MasaJF. Non-invasive positive airway pressure in obesity hypoventilation syndrome and chronic obstructive pulmonary disease: present and future perspectives. COPD, 2017; 14:418–428.
25.
KressJP, PohlmanAS, AlverdyJ, HallJB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med, 1999; 160(3):883–886.
26.
O'DonnellCP, SchaubCD, HainesAS, BerkowitzDE, TankersleyCC, SchwartzAR, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med, 1999; 159(5 I):1477–1484.
27.
IpMS, LamKS, HoC, TsangKW, LamW. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 2000; 118(3):580–586.
28.
CampoA, FrühbeckG, ZuluetaJJ, IriarteJ, SeijoLM, AlcaideAB, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J, 2007; 30(2):223–231.
29.
RedolfiS, CordaL, La PianaG, SpandrioS, PromettiP, TantucciC. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med, 2007; 101(6):1191–1195.
30.
PiperAJ, GrunsteinRR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med, 2011; 183:292–298.
31.
LemyzeM, TaufourP, DuhamelA, TemimeJ, NigeonO, VangrunderbeeckN, et al. Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One, 2014; 9(5):e97563.
32.
CarrilloA, FerrerM, Gonzalez-DiazG, Lopez-MartinezA, LlamasN, AlcazarM, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2012; 186(12):1279–1285.
33.
MasaJF, CelliBR, RiescoJA, HernandezM, Sanchez De CosJ, DisdierC, et al. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest, 2001; 119(4):1102–1107.
34.
MasaJF, CorralJ, AlonsoML, OrdaxE, TroncosoMF, GonzalezM, et al. Efficacy of different treatment alternatives for obesity hypoventilation syndrome: Pickwick study. Am J Respir Crit Care Med, 2015; 192(1):86–95.
35.
BorelJ-C, TamisierR, Gonzalez-BermejoJ, BaguetJ-P, MonneretD, ArnolN, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest, 2012; 141(3):692–702.
36.
PiperAJ, WangD, YeeBJ, BarnesDJ, GrunsteinRR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax, 2008; 63(5):395–401.
37.
HowardME, PiperAJ, StevensB, HollandAE, YeeBJ, DabscheckE, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax, 2017; 72(5):437–444.
38.
De Miguel DíezJ, De Lucas RamosP, Pérez ParraJJ, Buendía GarcíaMJ, Cubillo MarcosJM, González-MoroJMR. [Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results] Arch Bronconeumol, 2003; 39(7):292–297.
39.
BryC, JaffréS, Guyomarc'hB, CorneF, CholletS, MagnanA, BlancFX. Noninvasive ventilation in obese subjects after acute respiratory failure. Respir Care, 2018; 1:28–35.
40.
MurphyPB, DavidsonC, HindMD, SimondsA, WilliamsAJ, HopkinsonNS, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax, 2012; 67(8):727–734.
41.
WindischW. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J, 2008; 32(5):1328–1336.
